Free Trial
NASDAQ:AVDL

Avadel Pharmaceuticals Q2 2025 Earnings Report

Avadel Pharmaceuticals logo
$11.08 +0.57 (+5.42%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$11.02 -0.05 (-0.50%)
As of 08/1/2025 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Avadel Pharmaceuticals EPS Results

Actual EPS
N/A
Consensus EPS
$0.02
Beat/Miss
N/A
One Year Ago EPS
N/A

Avadel Pharmaceuticals Revenue Results

Actual Revenue
N/A
Expected Revenue
$60.28 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Avadel Pharmaceuticals Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Thursday, August 7, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

Avadel Pharmaceuticals Earnings Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
See More Avadel Pharmaceuticals Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Avadel Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avadel Pharmaceuticals and other key companies, straight to your email.

About Avadel Pharmaceuticals

Avadel Pharmaceuticals (NASDAQ:AVDL) plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

View Avadel Pharmaceuticals Profile

More Earnings Resources from MarketBeat